Metrics as of 10/16/2026, 08:35 AM (Berlin time), refresh in progress.
Phreesia Stock
Phreesia, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Country
- United States
- CEO
- Chaim Indig
- Employees
- 1,789
- Market cap
- $679 M
- IPO
- 18/07/2019
Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The…
Phreesia stock: price history
1D
-0.9%
1W
+1.2%
1M
+6.8%
6M
+19.3%
YTD
-35.3%
1Y
-51.9%
2Y
-47.5%
5Y
-82.8%
10Y
–
Next earnings date
Next earnings date
14/12/2026 (in 58 days)
Volatility around earnings
~85% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 15/10/26. Not a buy or sell signal.Beta
What does this mean?
Double bottom
BullishThe price bounced off a similar low twice, with a rally in between. This W-shaped pattern is a classic reversal signal from a downtrend into an uptrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about Phreesia
Analyst assessment of Phreesia
PRICE TARGET LOW
US$10.00
CONSENSUS
US$12.14
MEDIAN
US$12.00
PRICE TARGET HIGH
US$16.00
0
STRONG BUY
18
BUY
8
HOLD
0
SELL
0
STRONG SELL
26
TOTAL · Buy
As of: 12/10/2026
Phreesia stock metrics
P/E
63.53
P/B
1.82
EV/EBITDA
12.01
RETURN ON EQUITY
0.5%
NET MARGIN
1.5%
DEBT/EQUITY
0.18
DIVIDEND YIELD
0.0%
AS OF
31/07/2026
Free float & liquidity
FREE FLOAT
79.3%
FLOAT SHARES
49,232,190
AVG. DAILY VOLUME (30D)
689,144
Insider transactions (SEC)
Hoffman Allison C
VanDuyn Amy Beth
Roberts Evan
Linetsky David
Linetsky David
Institutional holders
Comparable stocks
Frequently asked questions about Phreesia stock
What does Phreesia do?
Phreesia, Inc. is a company in the Healthcare sector, Medical - Healthcare Information Services industry, headquartered in United States.
The CEO is Chaim Indig, the company employs around 1,789 people.
The IPO was on 18/07/2019; the stock trades on NYSE under the ticker PHR.
What do analysts say about Phreesia stock?
26 analysts rate the stock, the consensus is Buy (as of 12/10/2026).
The average price target is US$12.14, ranging from US$10.00 to US$16.00, with a median of US$12.00.
This is an external assessment, not a statement by Market Jury.
When does Phreesia report next?
The next earnings date is 14/12/2026.
Around past earnings, price swings were roughly 85% stronger than usual.
Does Phreesia pay a dividend?
No, Phreesia currently does not pay a dividend.
Which stocks are comparable to Phreesia?
Comparable stocks include Hinge Health, HealthEquity, Heartflow, Omada Health, Teladoc Health, Evolent Health, SOPHiA GENETICS and Optima Health.
How can I get Phreesia stock analyzed?
Clicking "Analyze stock" lets five strategies assess Phreesia against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.